【传默沙东(MRK.US)接近以100亿美元收购维罗纳制药(VRNA.US)】智通财经APP获悉,据报道,默沙东(MRK

智通财经
09 Jul
【传默沙东(MRK.US)接近以100亿美元收购维罗纳制药(VRNA.US)】智通财经APP获悉,据报道,默沙东(MRK.US)即将达成以约100亿美元收购呼吸药物制造商维罗纳制药(VRNA.US)的交易。知情人士表示,默沙东将以每ADS 107美元的价格收购这家生物技术公司,较后者周二收盘价溢价23%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10